Royal Bank of Canada’s Pulmatrix PULM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Buy
7
+1
+17% +$2 ﹤0.01% 7568
2025
Q4
$0 Buy
+6
New +$26 ﹤0.01% 7534
2021
Q3
Sell
-1
Closed 7814
2021
Q2
$0 Buy
+1
New +$20 ﹤0.01% 7637
2021
Q1
Sell
-410
Closed -$12.6K 7633
2020
Q4
$10K Hold
410
﹤0.01% 6382
2020
Q3
$10K Buy
+410
New +$10.4K ﹤0.01% 5927
2018
Q2
Sell
-26
Closed -$3K 6708
2018
Q1
$3K Buy
+26
New +$7.46K ﹤0.01% 6057
2017
Q4
Hold
0
6809
2017
Q3
Hold
0
6924
2017
Q2
Hold
0
6719

Other funds holding PULM

Royal Bank of Canada's PULM Position: Q1 2026 in Review

Royal Bank of Canada increased its Pulmatrix (PULM) stake by 17% in Q1 2026, buying an estimated $2 and bringing the position to 7 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7568.

Royal Bank of Canada first reported a position in PULM in Q1 2018 and has held it in 6 quarters since. The position peaked at $10K in Q4 2020. 15 funds tracked by Wall St. Rank hold PULM as of Q1 2026.

  • Royal Bank of Canada held 7 shares of Pulmatrix worth $0 as of Q1 2026.
  • Royal Bank of Canada bought 1 Pulmatrix share in Q1 2026, an estimated $2.
  • Pulmatrix made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7568 holding.
  • Royal Bank of Canada first reported a position in Pulmatrix in Q1 2018 and has held it in 6 quarters since.
  • Royal Bank of Canada's Pulmatrix position peaked at $10K in Q4 2020.
  • 15 funds tracked by Wall St. Rank held Pulmatrix as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.